Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] · 2014
Is sclerotherapy useful for cherry angiomas?
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Jairath Vijayeeta, Dayal Surbhi, Jain Vijay Kumar, Jindal Nidhi, Gogna Paritosh, Sehrawat Manu, Kaur Sarabjit, Verma Poonam
Аннотация
BACKGROUND: Sclerotherapy is a safe, effective, and easily available treatment modality, its role in cherry hemangioma is still unexplored.
OBJECTIVE: This study aims at establishing the role and efficacy of sclerotherapy in treating cherry angiomas and its dermatological complications.
MATERIALS AND METHODS: This prospective study included 20 patients with 100 lesions of cherry hemangiomas of size >0.2 mm. Intralesional injection of 0.1 mL of 3% sodium tetradecyl sulfate was used. Scarring, if any, was evaluated using "The Stony Brook Scar Evaluation Scale." Patients were called for weekly sessions for a maximum of 4 weeks.
RESULTS: Of 100 lesions treated, 42 lesions responded with a single dose of sclerosant, 44 lesions required a second setting. Remaining lesions were injected for 3 weeks, of which 14 lesions did not remit completely and required a fourth sitting. Depending on response to sclerotherapy, patients were divided into 2 groups (Group A and Group B). On comparing these groups, no statistically significant (χ test) difference in the rate of healing was observed.
CONCLUSION: Sclerotherapy with sodium tetradecyl sulfate 3% is effective in the treatment of cherry hemangiomas. It offers an economical alternative to other available conventional methods.
OBJECTIVE: This study aims at establishing the role and efficacy of sclerotherapy in treating cherry angiomas and its dermatological complications.
MATERIALS AND METHODS: This prospective study included 20 patients with 100 lesions of cherry hemangiomas of size >0.2 mm. Intralesional injection of 0.1 mL of 3% sodium tetradecyl sulfate was used. Scarring, if any, was evaluated using "The Stony Brook Scar Evaluation Scale." Patients were called for weekly sessions for a maximum of 4 weeks.
RESULTS: Of 100 lesions treated, 42 lesions responded with a single dose of sclerosant, 44 lesions required a second setting. Remaining lesions were injected for 3 weeks, of which 14 lesions did not remit completely and required a fourth sitting. Depending on response to sclerotherapy, patients were divided into 2 groups (Group A and Group B). On comparing these groups, no statistically significant (χ test) difference in the rate of healing was observed.
CONCLUSION: Sclerotherapy with sodium tetradecyl sulfate 3% is effective in the treatment of cherry hemangiomas. It offers an economical alternative to other available conventional methods.